Mencarini, J. et al. 2016. Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?. Reumatismo. 68, 3 (Dec. 2016), 144–147. DOI:https://doi.org/10.4081/reumatismo.2016.897.